Assessment of lipid peroxidation and antioxidant status in rheumatoid arthritis and osteoarthritis patients

Egyptian Rheumatologist

Volumn 33, Issue 4, 2011, Pages 179-185

  El barbary, Amal Mohamad ^a   Khalek, Manal Aly Abdel ^a   Elsalawy, Alaa Mohamad ^a   Hazaa, Sahar Mohyeldeen ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

Antioxidant status; Lipid peroxidation; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

ANTIOXIDANT; C REACTIVE PROTEIN; CATALASE; CERULOPLASMIN; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BLOOD LEVEL; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLUTATHIONE S TRANSFERASE BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE BLOOD LEVEL; OSTEOARTHRITIS; OXIDATIVE STRESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 84880395934     PISSN: 11101164     EISSN: 20902433     Source Type: Journal    
DOI: 10.1016/j.ejr.2011.07.002     Document Type: Article

References (57)

1. Mirshafiey A., Mohsenzadegan M. The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. Iran J Allergy Asthma Immunol 2008, 7(4):195-202.
2. Henrotin Y., Kurz B., Aigner T. Oxygen and reactive oxygen species in cartilage degradation: friends or foes?. Osteoarthr Cartil 2005, 13:643-654.
3. Afonso V., Champy R., Mitrovic D., Collin P., Lomri A. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine 2007, 74:324-329.
4. Valko M., Leibfritz D., Moncol J., Cronin M.T.D., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
5. Gambhir J.K., Lali P., Jain A.K. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 1997, 30:351-355.
6. Romero F.J., Bosch-Morell F., Romero M.J., Jareño E.J., Romero B., Marín N., et al. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect 1998, 106:1229-1234.
7. Lunec J., Halloran S.P., White A.G., Dormandy T.L. Free radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 1981, 8:233-245.
8. McCord J.M., Edeas M.A. SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed Pharmacother 2005, 59:139-142.
9. Henrotin Y., Kurz B. Antioxidant to treat osteoarthritis: dream or reality?. Curr Drug Targets 2007, 8(2):347-357.
10. Nagler R.M., Salameh F., Reznick A.Z., Livshits V., Nahir A.M. Salivary gland involvement in rheumatoid arthritis and its relationship to induced oxidative stress. Rheumatology 2003, 42(10):1234-1241.
11. Sarban S., Kocyigit A., Yazar M., Isikan U.E. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 2005, 38:981-986.
12. Ozturk H.S., Cimen M.Y., Cimen O.B., Kacmaz M., Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 1999, 19:35-37.
13. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31(3):315-324.
14. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the american rheumatism association. Arthritis Rheum 1986, 29:1039-1049.
15. Prevoo M.L., Van't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48.
16. Bellamy N., Goldsmith C.H., Buchanan W.W., Campbell J., Duku E. Prior score availability: Observations using the WOMAC osteoarthritis index. Br J Rheumatol 1991, 30:150-151.
17. Salaffi F., Leardini G., Canesi B., Mannoni A., Fioravanti A., Caporali R., et al. Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee. Osteoarthritis Cartilage 2003, 11:551-560.
18. Okhawa H., Ohishi N., Yagi K. Assay for lipid peroxidase in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
19. Marklund S., Marklund G. Involvement of superoxide anion radical in the auto-oxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1979, 47:469-474.
20. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
21. Beutler E., Duron O., Kelly B.M. Improved method for the determination of blood glutathione. J Lab Clin Med 1963, 61:882-888.
22. Adachi Y., Horii K., Takahashi Y., Tanihata M., Ohba Y., Yamamoto T. Serum glutathione-S-transferase activity in liver diseases. Clin Chim Acta 1980, 106:243-255.
23. Sunderman F.W., Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem 1970, 16(11):903-910.
24. Kumagai S., Jikimoto T., Saegusa J. Pathological roles of oxidative stress in autoimmune diseases. Rinsho Byori 2003, 51(2):126-132.
25. Akyol O., Iscedilçi N., Temel I., Özgöçmen S., Uz E., Murat M., et al. The relationships between plasma and erythrocyte antioxidant enzymes and lipid peroxidation in patients with rheumatoid arthritis. Joint Bone Spine 2001, 68:311-317.
26. Jaswal S., Mehta H.C., Sood A.K., Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 2003, 338:123-129.
27. Ozgunes H., Gurer H., Tuncer S. Correlation between plasma Malondialdehyde and ceruloplasmin activity values in rheumatoid arthritis. Clin Biochem 1995, 28:193-194.
28. Olivieri O., Girelli D., Trevisan M.T., Bassi A., Zorzan P., Bambara L.M., et al. Red blood cell susceptibility to lipid peroxidation, membrane lipid composition and antioxidant enzymes in patients with rheumatoid arthritis. J Rheumatol 1991, 18:1263-1264.
29. Maneesh M., Jayalekshmi H., Suma T., Chatterjee S., Chakrabarti A., Singh T.A. Evidence for oxidative stress in osteoarthritis. Indian J Clin Biochem 2005, 20(1):129-130.
30. Rubyk B.I., Fil'chagin N.M., Sabadyshin R.A. Change in lipid peroxidation in patients with primary osteoarthrosis deformans. Ter Arkh 1988, 60(9):110-113.
31. Cimen M.Y.B., Cimen O.B., Kacmaz B., Ozturk H.S., Yorgancioglu R., Durak I. Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin Rheumatol 2000, 19:275-277.
32. Taysi S., Polat F., Gul M., Sari R.A., Bakan E. Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with RA. Rheumatol Int 2002, 21:200-204.
33. Recklies AD, Poole AR, Banerjee S, Bogoch E, Dibattista J, Evans CH, et al. Pathophysiologic aspects of inflammation in diarthroidal joints. In: Buckwalter JA, Einhorn TA, Simon SR, editors. Orthopaedic basic science: biology and biomechanics of the musculoskeletal system, 2nd ed. Rosemont, IL: AAOS; 2000. p. 489-530.
34. Karatas F., Ozates I., Canatan H., Halifeoglu I., Karatepe M., Colak R. Antioxidant status & lipid peroxidation in patients with RA. Indian J Med Res 2003, 118:178-181.
35. Banford J.C., Brown D.H., Hazelton R.A., McNeil C.J., Sturrock R.D., Smith W.E. Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis. Ann Rheum Dis 1982, 41:458-462.
36. Imayada A., Terasawa K., Tosa H., Okamoto M., Toriizuka K. Erythrocyte antioxidant enzymes are reduced in patients with rheumatoid arthritis. J Rheumatol 1988, 15:1628-1631.
37. Kalpakcioglu B., Şenel K. The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of RA. Clin Rheumatol 2008, 27:141-145.
38. Pinto S., Rao A.V., Rao A. Lipid peroxidation, erythrocyte antioxidants and plasma antioxidants in osteoarthritis before and after homeopathic treatment. Homeopathy 2008, 97(4):185-189.
39. Ostalowska A., Birkner E., Wiecha M., Kasperczyk S., Kasperczyk A., Kapolka D., et al. Lipid peroxidation and antioxidant enzymes in synovial fluid of patients with primary and secondary osteoarthritis of the knee joint. Osteoarthr Cartil 2006, 14(2):139-145.
40. Ivanova E., Ivanova B. Mechanisms of extracellular antioxidant defence. Exp Pathol 2000, 4:49-59.
41. Surapaneni K.M., Venkataramana G. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with osteoarthritis. Indian J Med Sci 2007, 61(1):9-14.
42. El-Sohemy A., Cornelis M.C., Park Y.W., Bae S.C. Catalase and PPARgamma2 genotype and risk of rheumatoid arthritis in Koreans. Rheumatol Int 2006, 26:388-392.
43. Strange R.C., Spiteri M.A., Ramachandran S., Fryer A.A. Glutathione S-transferase family of enzymes. Mutat Res 2001, 482:21-26.
44. Vaillancourt F., Fahmi H., Shi Q., Lavigne P., Ranger P., Fernandes J.C., et al. 4-Hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: the protective role of glutathione-S-transferase. Arthr Res Ther 2008, 10(5):R107.
45. Hassan M.Q., Hadi R.A., Al-Rawi Z.S., Padron V.A., Stohs S.J. The glutathione defence system in the pathogenesis of RA. J Appl Toxicol 2001, 21(1):69-73.
46. Cogalgil S., Tays S. Levels of antioxidant proteins and soluble intercellular adhesion molecule-1 in serum of patients with rheumatoid arthritis. Ann Clin Lab Sci 2002, 32:264-270.
47. Lopez-Avila V., Sharpe A., Robinson W.H. Determination of ceruloplasmin in human serum by SEC-ICPMS. Anal Bioanal Chem 2006, 386:180-187.
48. Kamanl A., Naziroglu M., Aydilek N., Hacievliyagil C. Plasma lipid peroxidation and antioxidant levels in patients with RA. Cell Biochem Funct 2004, 22(1):53-57.
49. Denko C.W., Gabriel P. Serum proteins-transferrin, ceruloplasmin, albumin, alpha 1-acid glycoprotein, alpha 1-antitrypsin-in rheumatic disorders. J Rheumatol 1979, 6(6):664-672.
50. Dixon J.S., Greenwood M., Lowe J.R. Cp concentration and oxidase activity in polyarthritis. Rheumatol Int 1988, 8(1):11-14.
51. Surrall K.E., Bird H.A., Dixon J.S. Caeruloplasmin, prealbumin and alpha 2-macroglobulin as potential indices of disease activity in different arthritides. Clin Rheumatol 1987, 6(1):64-69.
52. Gutteridge J.M. Antioxidant properties of the proteins caeruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis. Biochem Biophys Acta 1986, 869(2):119-127.
53. Kose K., Dogan P., Kardas Y., Saraymen R. Lipid peroxidation and antioxidant activity in rheumatoid arthritis. Turk J Med Sci 1994, 22:31-34.
54. Darlington L.G., Stone T.W. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br J Nutr 2001, 85:251-269.
55. Ashour M., Salem S., Hassaneen H., El-Gadban H., Elwan N., Awad A., et al. Antioxidant status in children with juvenile rheumatoid arthritis living in Cairo, Egypt. Int J Food Sci Nutr 2000, 51:85-90.
56. Louro M.O., Cocho J.A., Mera A., Tutor J.C. Immunochemical and enzymatic study of ceruloplasmin in rheumatoid arthritis. J Trace Elem Med Biol 2000, 14(3):174-178.
57. Baskol G., Demir H., Baskol M., Kilic E., Ates F., Kocer D., et al. Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 2005, 38:951-955.